Federal Register Notice: FDA is seeking comments on the information collection provisions of the FD&C Act and the document Guidance for Industry: Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act. Comments should be submitted by 1/5/15. To view this notice, click here.
